Colorectal Carcinoma Notes
Overview of Colorectal Carcinoma
- Arises from colonic or rectal mucosa.
- Peak incidence: ages 60 to 70.
- Third most common cancer (excluding skin) and third leading cause of cancer-related deaths.
Molecular Mechanisms of Colorectal Carcinoma
- Two major pathways:
- Adenoma-Carcinoma Sequence
- The most common pathway, accounting for ~80% of colorectal cancers.
- Involves progression from adenoma (benign polyp) to carcinoma.
- Microsatellite Instability (MSI) Pathway
- Involves defects in DNA mismatch repair enzymes leading to instability in microsatellites (repeating non-coding DNA sequences).
- Major example: Hereditary Non-Polyposis Colorectal Carcinoma (HNPCC).
- Inherited mutation in DNA mismatch repair enzymes.
- Increased risks for colorectal, ovarian, and endometrial carcinomas.
Additional Risk Factors
- Ulcerative Colitis:
- Chronic inflammation increases risk for colorectal cancer.
- Peutz-Jeghers Syndrome:
- Associated with increased risk for colorectal carcinoma.
Screening for Colorectal Carcinoma
- Common methods:
- Colonoscopy
- Correcting the transcript from "endoscopy" to "colonoscopy".
- Aims to remove adenomatous polyps before they become cancerous.
- Fecal Occult Blood Testing
- Detects bleeding from polyps or cancers, ideally screening begins at age 50.
Characteristics of Colorectal Carcinoma
- Cancer can occur anywhere along the colon:
- Left-Sided Carcinoma:
- Grows as a napkin ring lesion affecting the bowel lumen, leading to:
- Decreased stool caliber (pencil-thin stools).
- Left lower quadrant pain.
- Possible blood streaking in stool.
- Right-Sided Carcinoma:
- Grows as a raised lesion on the surface of colonic mucosa.
- Symptoms include:
- Iron deficiency anemia due to chronic blood loss.
- Vague abdominal pain.
Associated Conditions
- Streptococcus bovis Endocarditis:
- Increased association with colorectal carcinoma.
- Important for clinical examination when noted in endocarditis patients.
Staging of Colorectal Carcinoma
- T Stage: Depth of invasion into the bowel wall.
- N Stage: Involvement of regional lymph nodes.
- M Stage: Distant spread, most commonly to the liver.
Tumor Markers
- Carcinoembryonic Antigen (CEA):
- Not useful for screening but important for:
- Assessing treatment response (decrease after effective treatment).
- Detecting recurrence (elevated levels may indicate return of disease).